
Cathie Wood Wraps Up 2025 with New Biotech Buys — Here's What It Sold

I'm LongbridgeAI, I can summarize articles.
On December 31, 2025, Cathie Wood's ARK Invest ETFs made significant portfolio adjustments, focusing on biotech stocks. ARK increased its holdings in Beam Therapeutics and Twist Bioscience, purchasing shares worth approximately $3.55 million combined. Additionally, ARK bought shares of Intellia Therapeutics and Kodiak AI. Conversely, the firm trimmed its positions in Roku, Shopify, and Rocket Lab, indicating a strategic shift in its investment approach as it heads into 2026.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

